Perifosine can also boost Bevacizumab’s proapoptotic effects and reverse Bevacizumab’s upregulation of phospho-AKT and MMP2 levels in C6 xenografts, resulting in better antiproliferative activity, reduced tumor development, and prolonged survival [178]. Here, AKT1 is linked to neoplasm.